AmideBio LLC

---

Boulder’s AmideBio wins SBIR grant for diabetes treatment research

 September 16, 2024 12:59:10 pm

---

AmideBio secures $2.7M SBIR grant

 October 4, 2022 7:12:01 am

---

CEO Roundtable: Biotech leaders enjoy deep interest from investors amid pandemic

 April 28, 2021 8:12:38 pm

---

FDA grants rare disease drug status to AmideBio’s pediatric hyperinsulinism treatment

 August 20, 2020 6:52:58 pm

---

FDA grants orphan status to AmideBio drug

 April 23, 2020 7:01:11 pm

---

Improving access to capital, talent a priority for Boulder biotech firms

 April 23, 2019 8:22:30 pm

---

New president for AmideBio

 September 4, 2018 8:16:31 pm

---

Diabetes-industry veteran Fludzinski named CEO of AmideBio

 May 16, 2018 7:02:24 pm

---

Boulder’s bioscience industry growing to critical mass

 April 18, 2018 9:16:19 pm

---

Biopharma company AmideBio raises more than $700,000

 November 8, 2017 8:57:23 pm

Next Page »